The Burrill Report (March 31, 2014): Why There's Growing Talk of a Biotech Bubble (.MP3,14.1 Mb)

A biotech sell-off in March has some investors jittery as the dramatic rise of stocks in the sector over the past two years has fueled talk of a biotech bubble. We spoke to Adam Feuerstein, senior columnist with TheStreet.com, about the trading activity in March, if there’s cause for concern about a bubble, and whether growing scrutiny of drug prices will bring the biotech party on Wall Street to a crashing halt.